Search research articles
Contact Us
Filters
Showing results (331-340 of 366) with videos related to
Page
of 37
Sort By:
Journal of Clinical Immunology
|
April 1, 1982
Use of intravenous immune globulin in patients receiving bone marrow transplants
D J Winston, W G Ho, L E Rasmussen, et al.
JAMA
|
January 5, 1979
Toxicity of vidarabine
S L Sacks, J L Smith, R B Pollard, et al.
Annals of Internal Medicine
|
February 1, 1989
Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. A phase I and II study
T C Merigan, G Skowron, S A Bozzette, et al.
Virology
|
November 1, 1988
Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage
R R Spaete, R M Thayer, W S Probert, et al.
The Journal of Infectious Diseases
|
April 1, 1991
Detection and quantification of human immunodeficiency virus RNA in patient serum by use of the polymerase chain reaction
M Holodniy, D A Katzenstein, S Sengupta, et al.
Journal of Virology
|
April 1, 1991
Absent or rare human immunodeficiency virus infection of bone marrow stem/progenitor cells in vivo
B R Davis, D H Schwartz, J C Marx, et al.
Reviews of Infectious Diseases
|
July 1, 1988
Ganciclovir treatment of serious cytomegalovirus infection in heart and heart-lung transplant recipients
S Keay, E Petersen, T Icenogle, et al.
The Journal of Clinical Investigation
|
November 20, 1998
A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors
M A Winters, K L Coolley, Y A Girard, et al.
Journal of Clinical Microbiology
|
April 3, 2001
High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patients
R W Shafer, K Hertogs, A R Zolopa, et al.
Annals of Internal Medicine
|
February 15, 1990
Recombinant soluble CD4 therapy in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase I-II escalating dosage trial
R T Schooley, T C Merigan, P Gaut, et al.
Page
of 37
Search research articles
Search
Showing results (331-340 of 366) with videos related to
Sort By:
Page
of 37
Journal of Clinical Immunology
|
April 1, 1982
Use of intravenous immune globulin in patients receiving bone marrow transplants
D J Winston, W G Ho, L E Rasmussen, et al.
JAMA
|
January 5, 1979
Toxicity of vidarabine
S L Sacks, J L Smith, R B Pollard, et al.
Annals of Internal Medicine
|
February 1, 1989
Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. A phase I and II study
T C Merigan, G Skowron, S A Bozzette, et al.
Virology
|
November 1, 1988
Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage
R R Spaete, R M Thayer, W S Probert, et al.
The Journal of Infectious Diseases
|
April 1, 1991
Detection and quantification of human immunodeficiency virus RNA in patient serum by use of the polymerase chain reaction
M Holodniy, D A Katzenstein, S Sengupta, et al.
Journal of Virology
|
April 1, 1991
Absent or rare human immunodeficiency virus infection of bone marrow stem/progenitor cells in vivo
B R Davis, D H Schwartz, J C Marx, et al.
Reviews of Infectious Diseases
|
July 1, 1988
Ganciclovir treatment of serious cytomegalovirus infection in heart and heart-lung transplant recipients
S Keay, E Petersen, T Icenogle, et al.
The Journal of Clinical Investigation
|
November 20, 1998
A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors
M A Winters, K L Coolley, Y A Girard, et al.
Journal of Clinical Microbiology
|
April 3, 2001
High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patients
R W Shafer, K Hertogs, A R Zolopa, et al.
Annals of Internal Medicine
|
February 15, 1990
Recombinant soluble CD4 therapy in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase I-II escalating dosage trial
R T Schooley, T C Merigan, P Gaut, et al.
Page
of 37